Praziquantel is NOT the appropriate treatment for Fasciola hepatica infection
For Fasciola hepatica, use triclabendazole 10 mg/kg once daily for 2 days as first-line therapy, NOT praziquantel. If praziquantel must be used (when triclabendazole is unavailable), the dose is 25 mg/kg three times daily for 2 days, though efficacy is poor 1.
Why Triclabendazole is Preferred
Fasciola hepatica is uniquely resistant to praziquantel among trematode infections. The most recent UK guidelines (2025) explicitly recommend triclabendazole as the treatment of choice 1. The guidelines do list praziquantel as an alternative option, but this reflects availability issues rather than optimal efficacy.
Evidence Against Praziquantel for Fasciola
Research consistently demonstrates praziquantel's poor performance:
- A 1985 Peruvian study showed only 21% of patients stopped excreting eggs despite repeated praziquantel treatment, leading investigators to conclude "praziquantel is not very active against F. hepatica in man" 2
- A 1995 French study using 75 mg/kg/day for 5 days achieved only 72% complete recovery 3
- A 2026 case report emphasizes that Fasciola "is resistant to praziquantel and must be treated with triclabendazole" 4
Dosing When Praziquantel Must Be Used
If triclabendazole is unavailable, the guideline-recommended praziquantel regimen is:
Praziquantel 25 mg/kg orally three times daily for 2 days 1
Alternative regimen from older literature: 75 mg/kg/day divided into multiple doses for 5 days 3, though this is not guideline-supported.
Critical Caveats
- Increasing triclabendazole resistance is documented, particularly in endemic areas like Peru 1, 5
- When triclabendazole fails, seek expert infectious disease consultation rather than defaulting to praziquantel
- Dexamethasone reduces praziquantel levels through increased metabolism; use prednisolone if steroids are needed 1
- Fasciola can be confused with other liver flukes (Fasciolopsis buski, Opisthorchis, Clonorchis) that DO respond to praziquantel—accurate species identification is essential 4
Treatment Monitoring
Follow clinical symptoms, eosinophil counts, and serology at 6,9, and 12 months. Expect normalization of eosinophilia in 75% by 12 months and seronegativation in 100% with effective treatment 3.